Veru settles $8.8 million debt with Onconetix for cash, preferred stock, and warrants
PositiveFinancial Markets

Veru has successfully settled an $8.8 million debt with Onconetix, using a combination of cash, preferred stock, and warrants. This move not only alleviates financial pressure on Veru but also strengthens its balance sheet, allowing the company to focus on its core operations and future growth. Such settlements are crucial for companies looking to stabilize their finances and enhance investor confidence.
— Curated by the World Pulse Now AI Editorial System